🟢 THG is trading 7.8% up with no confirmed fresh catalyst

THG is trading at £39.02, up 7.79% at the October 21 close; no new company announcement was identified for October 21 or 22.

• On October 15, THG raised FY26 adjusted EBITDA guidance to £103 million, above analyst consensus, citing stronger Nutrition performance and favourable whey pricing. This is prior context, not a confirmed fresh catalyst.
• The FTSE 250 gained 0.31%, too modest to explain THG’s much larger rise on its own.